Ординатура / Офтальмология / Английские материалы / The Eye Care Sourcebook_Lavine_2001
.pdfB I B L I O G R A P H Y
——— “Cataracts and Riboflavin Deficiency.” The American Journal of Clinical Nutrition 34 (1981): 861–63.
Stocker, Frederick W., Lawrence B. Holt, and James W. Clower. “Clinical Experiments with New Ways of Influencing Intraocular Tension. I. Effect of Rice Diet.” Archives of Ophthalmology 40 (1948): 46–55.
Stulting, R. Doyle, Jonathan D. Carr, Keith P. Thompson, George O. Waring III, Wendy M. Wiley, and Judy G. Walker. “Complications of Laser in Situ Keratomileusis for the Correction of Myopia.” Ophthalmology 106 (1999): 13–20.
Stur, Michael, Michael Tittl, Andreas Reitner, and Vanee Meisinger.“Oral Zinc and the Second Eye in Age-Related Macular Degeneration.” Investigative Ophthalmology and Visual Science 37 (1996): 1225–35.
Taylor, Allen, Paul F. Jacques, T. Nowell, G. Perrone, J. Blumberg, G. Handelman, B. Jozwiak, and D. Nadler.“Vitamin C in Human and Guinea Pig Aqueous, Lens and Plasma in Relation to Intake.” Current Eye Research 16 (1997): 857–64.
Van Eck, William F. “The Effect of a Low-Fat Diet on the Serum Lipids in Diabetes and Its Significance in Diabetic Retinopathy.” American Journal of Medicine 27 (1959): 196–211.
Waring, George O., III, Jonathan D. Carr, R. Doyle Stulting, Wendy M. Wiley, David Huang, and Keith P. Thompson. “LASIK for Myopia and Astigmatism in 2,100 Consecutive Eyes Using a Nidek EC-5000 Excimer Laser.” Investigative Ophthalmology and Visual Science 40 (1999): S588.
Yeum, Kyung-Jin, Fu Shang, Wolfgang Schalch, Robert M. Russell, and Allen Taylor. “Fat-Soluble Nutrient Concentrations in Different Layers of Human Cataractous Lens.” Current Eye Research 19 (1999): 502–5.
328
Index
Page references in italic refer to illustrative material
Abrasions, corneal, 11, 83–85, 91 Accommodation, 14, 27, 110, 122 Accommodative esotropia, 110–11 Acne rosacea, 61
Acquired immunodeficiency syndrome. See AIDS
Aging, and presbyopia, 14, 15, 27–28, 40
AIDS (acquired immunodeficiency syndrome) in cytomegalovirus retinitis, 263–66
in eyelid problems, 268–69
in human immunodeficiency virus, 263 in other forms of retinitis, 266–68 recommendations for, 269
retinal problems in, 268 Alcohol
cataracts and, 135 glaucoma and, 159
macular degeneration and, 207 optic nerve damage and, 233
Allergies
acute reactions, 100–101 to contact lens solutions, 50 hay fever, 98–100
to medications, 23 vernal, 101
Alzheimer’s disease, 196 Amblyopia (lazy eye), 109, 111–12
ptosis and, 80 tobacco alcohol, 233
Amino acids, 280–82 Amsler grid, 29, 208, 223–24
Aneurysms, 119, 227, 233, 250 microaneurysms, 177–78, 179
Angiography, fluorescein, 178, 208, 223
Angle-closure glaucoma, 14 surgery for, 167–68
tranquilizers/antidepressants and, 274 types of, 149–50
Angle recession, 35 Ankylosing spondylitis, 242 Anterior chamber, 10, 13, 33
Antibiotics, 23. See also Medications; specific diseases
Anticancer drugs, 274–75 Antidepressants, 273–74 Antihistamines, 99–100
Anti-inflammatory drugs, 271–73. See also Corticosteroids
Antioxidants
carotenoids, 128, 131, 199–200, 201–3, 287 in cataract prevention, 128–33, 143 defined, 125, 198
in gingko biloba, 166 lutein, 131–32, 142, 201–3
macular degeneration and, 197–203, 205 niacin (vitamin B3), 132, 288
in protection of the retina, 198–200 riboflavin (vitamin B2), 132, 287–88 in tea, 133
vitamin C, 125, 129–30, 143, 292 vitamin E, 125, 130–31, 143, 293
Apraclonidine, 153 Aqueous humor, 9, 13, 14
Argon laser trabeculoplasty, 168–69 Arteritis, temporal/giant cell, 218, 230–31 Artery, central retinal
anatomy of, 10, 17–18 occlusions of, 217–20
Arthritis
juvenile rheumatoid, 243
in spine (ankylosing spondylitis), 238, 242
329
Copyright 2001 by Jay B. Levine. Click Here for Terms of Use.
|
I N D E X |
Ascorbic acid. See Vitamin C |
Blood circulation |
Aspirin, 184, 248 |
in glaucoma, 151, 164–65 |
Astigmatism |
in smokers, 157 |
defined, 27, 39–40 |
Blood pressure, 207, 215–17, 220 |
irregular, 11, 40, 90 |
Blood sugar |
Atherosclerosis, 205 |
in diabetes, 173, 174–76, 180 |
Autoimmune diseases |
effect on eyes, 176–77 |
and optic neuritis, 233 |
Blood vessels, retinal |
uveitis, 235–36 |
anatomy of, 10, 17–18 |
|
examination of, 34 |
Bacterial infections |
in HIV infections, 267 |
conjunctivitis, 94, 97–98 |
occlusions of |
in cornea, 90–91 |
arterial, 5–6, 216, 217–20 |
of eyelids, 59, 61–62, 63 |
vein, 216, 220–22 |
Bandage lens, 85, 88–89 |
Blood viscosity, 164–65, 166–67 |
Basal cell carcinomas, 76–77 |
Blowout fractures, 117 |
Base-down triangle procedure, 79 |
Bowman’s membrane, 11 |
Benign intracranial hypertension, 233 |
Bruch’s membrane, 16–17, 188 |
Beta blockers, 151–52, 249 |
|
Beta-carotene, 200, 201, 287 |
Caffeine, 157–58 |
Betaxolol, 151, 152 |
Calcium, 297–98 |
Betoptic (betaxolol), 151, 152 |
Canaliculi, 70 |
Bifocals, 40–41, 44 |
Canal of Schlemm, 10, 13 |
Biomicroscope, 32, 87 |
Capsule of lens, 16, 123 |
Biopsies, 218, 230–31 |
Carbohydrates, 279–80 |
Biotin, 291 |
Carbonic anhydrase inhibitors, 154 |
Bleeding |
Carcinomas, 76–77 |
in anterior chamber, 13 |
Carotenoids |
in hypertensive retinopathy, 216 |
and macular degeneration, 199–200, |
cause of optic nerve damage, 232–33 |
201–2, 205 |
on optic disk,147 |
in preventing cataracts, 128, 131 |
in retina, 178 |
and vitamin A, 287 |
subconjunctival hemorrhage, 105–6 |
Cataracts |
after vein occlusions, 221 |
and corticosteroids, 135, 271–72 |
in vitreous humor, 16 |
crystalline lens in, 122–23, 125–26 |
Blepharitis (eyelid inflammation) |
defined, 1, 16, 121 |
and allergies, 100 |
in diabetes, 124, 135, 176 |
angular, 61 |
diagnosing, 1, 33 |
causes of, 60–61 |
effect on vision, 26, 121–22 |
and conjunctivitis, 97 |
formation of, 124–25 |
defined, 59 |
hypermature, 122 |
in dystrophies, 90 |
prevention of, 126–27 |
eczematoid, 61 |
antioxidants in, 128–33, 143 |
problems caused by, 61–62, 64–65 |
and dairy foods, 133–35 |
seborrheic, 59, 62, 63 |
lutein in, 131–32, 142 |
staphylococcal, 59, 61–62, 63 |
vitamin C in, 125, 129–30, 143 |
susceptibility to, 61 |
vitamin E in, 130–31, 143 |
symptoms of, 29–30, 60 |
vitamin supplements in, 127–28 |
treating, 62–64 |
recommendations for, 142–43 |
Blindness |
risk factors for, 127, 135–36 |
from glaucoma, 145 |
surgery for, 1, 136–42, 143 |
legal definition of, 25 |
alternatives to, 138–39 |
sudden, 5–6 |
combining with glaucoma surgery, 169 |
Blinking, lack of, 255 |
complications of, 126, 141–42 |
Blood-aqueous barrier, 160 |
epidemic of, 136–37 |
330
I N D E X
incision size in, 140–41 indications for, 137–38 procedure for, 139–40
types of
cortical, 16, 123, 124
nuclear sclerotic, 16, 123, 124, 135 posterior subcapsular, 123, 134, 135,
138, 271 secondary, 142, 211
in uveitis, 238 Cellophane maculopathy, 215 Chalazia
defined, 64
and oil gland tumors, 74–75 susceptibility to, 64–65 treatment of, 65–66
Chemicals in eyes, 5 Children
amblyopia in, 111–12 esotropia in, 2, 108–11 exotropia in, 113–14
getting eyedrops into eyes, 98 glaucoma in, 150
hyperopia in, 109, 110, 111 nutrition in eye health, 268–71 ptosis in, 79–80
tear duct problems in, 70–71 Chlamydial conjunctivitis, 96–97 Cholesterol
drugs to lower, 182, 275
and macular degeneration, 203–5 and retinopathy, 180–82
and zinc, 194–95 Choroid, 9, 10, 16–17, 188, 235 Choroiditis, 17
Chronic angle-closure glaucoma, 149, 274 Chronic open angle glaucoma
blood circulation in, 151 defined, 14, 149, 150
effect of medications on, 273–74 and omega-3 fatty acids in, 165 surgery for, 168–70
Ciliary body
description of, 9, 10, 14, 235 partial destruction of, 170
Clindamycin, 225, 226 CMV. See Cytomegalovirus
Cobalamin (vitamin B12), 233, 289–90 Colitis
pseudomembranous, 226 ulcerative, 242
Color vision, 36 Cones, 17, 188, 269 Congenital disorders
dacryostenosis, 70–71
esotropia, 108, 109–11 glaucoma, 150
Conjunctiva. See also Conjunctivitis anatomy of, 10, 12–13 disorders of
allergies, 98–101 episcleritis, 101–3 pinguecula, 105 pterygium, 103–4
subconjunctival hemorrhage, 105–6
examination of, 33 foreign bodies in, 6, 85–86
Conjunctivitis bacterial, 94, 97–98
caused by herpes simplex, 96, 257 causes of, 93
in children, 98 chlamydial, 96–97 defined, 13
giant papillary, 50–51 phlyctenular, 61–62 viral, 93–96
Contact lenses, 45–51 advantages/disadvantages of, 45–46 after cataract surgery, 140
bandage lens, 85, 88–89 choosing, 48–49
costs of, 49 examination for, 49 and eyes changing, 2 fittings, 49–50 follow-up care, 50 in presbyopia, 47–48
problems with, 7, 11, 50–51, 91 types of, 46–47
Convergence amplitudes, 36–37, 115 Convergence insufficiency, 113–15, 244 Copper, 191–93, 300–301
Cornea
abrasions of, 11, 83–85, 91 anatomy of, 9, 10–12, 10 clouding of, 87–90, 141 edema of, 11–12, 46, 51, 87–89 effect of diabetes on, 176 endothelial cell loss in, 87–88 examination of, 32–33 foreign bodies in, 6, 85–87 infections of, 90–93, 257–59 lacerations to, 11, 85
scarring of, 11 transplantation of, 89 ulcers of, 11, 50, 90–93
Cortex of lens, 15–16, 123 Cortical cataracts, 16, 123, 124
331
I N D E X
Corticosteroids
and cataracts, 135, 271–72 in conjunctivitis, 96
in herpes infections, 258, 259, 262 in optic neuritis, 229
side effects of, 100, 271–72 in temporal arteritis, 231 in toxoplasmosis, 225–26 in uveitis, 240–41
Cotton wool spots, 216 Crohn’s disease, 242 Crossed eyes. See Esotropia Cryotherapy, 170, 212, 213 Crystalline lens. See Lens Crystallins, 123
Cup/disk ratio, 146 Cup of optic disk, 146 Cyclitis, 235 Cyclocryotherapy, 170
Cyst, epithelial inclusion, 74 Cytomegalovirus (CMV), 263–66
Dacryoadenitis, 74 Dacryocystorhinostomy (DCR), 72–73 Dacryostenosis, congenital, 70–71 Dairy foods, 133–35
Dandruff, 62 Dazzle test, 36 Dendrites, 257, 261
Depth perception, 31, 107 Descemet’s membrane, 12
DHA (Docosahexaenoic acid), 270–71 Diabetes mellitus
cataracts in, 124, 135, 176 complications of, 174–77 diet in, 3, 174–76
nerve palsies in, 118 recommendations for, 186 retinopathy in, 177–86
and aspirin, 184
background retinopathy, 177, 179 and cholesterol, 180–82 controlling naturally, 180–83 and diet, 180–82
and gingko biloba, 185–86 hard exudates in, 178, 179–82 laser treatments in, 178–80 and magnesium, 183–84, 299 and omega-3 fatty acids, 185 proliferative, 178
and vitamin E, 184–85 types of, 173–74
Diabetic maculopathy, 179 Diet. See Nutrition Disciform keratitis, 259
Divergence amplitudes, 36–37, 115 Docosahexaenoic acid (DHA), 270–71 Double vision
determining cause of, 116–17 in diabetes, 176
and muscle problems, 117 and nerve palsies, 117–19
and transient ischemic attacks, 120 Drugs. See Medications
Drusen, 188
Dry eye syndrome
with contact lenses, 47 in dystrophies, 90
and laser surgery, 54–55
and reading problems, 121–22 risk factors for, 67
and risk of infection, 91 treatment of, 68–69 types of, 67–68
Duke-Elder, Stewart, 162 Dye disappearance test, 72 Dystrophies
Fuch’s, 87–88 granular, 90 lattice, 90 macular, 90
map-dot fingerprint, 89–90
Early Treatment Diabetic Retinopathy Study (ETDRS), 179
Ectropion, 73, 77–78, 78 Eczematoid blepharitis, 61 Edema
corneal
causes of, 87
and contact lenses, 46, 51 defined, 11–12 diagnosing, 87–88 treating, 88–89
macular, 275 Eicosapentaenoic acid (EPA), 270 Elderly, cholesterol and zinc in, 195 Endothelial cells, 12, 87–89 Entropion, 73, 77–79
EPA (Eicosapentaenoic acid), 270 Epinephrine eyedrops, 152–53 Epiphora, 30, 71
Epiretinal membrane, 214 Episcleritis, 101–3, 106
and blepharitis, 61
in contact lens wearers, 51 Epithelial cells of lens, 123 Epithelial inclusion cyst, 74 Epithelium of cornea, 10–11 Esophoria, 36–37, 115
332
I N D E X
Esotropia, 2 accommodative, 110–11 infantile, 108, 109–11 pseudoesotropia, 108 treating, 109–11
Exercise, aerobic, 156–57, 166 Exercises, eye, 2, 113, 114–15 Exophoria, 36–37, 114, 115 Exophthalmos, 252, 253 Exotropia, 113–15
External hordeolum. See Styes Exudates, hard, 178, 179–82 Eye charts, 24–26
Eye Disease Case-Control Study, 199, 202, 204 Eye diseases. See also specific diseases
prevention with nutrition, 3, 277–79 Eyedrops. See also specific disorders
anesthetic (numbing), 84, 86 artificial tears, 63–64, 68 cycloplegic, 239
in diagnosing disorders, 37 dilating, 84, 138–39 getting into child’s eyes, 98
Eye examinations
for color vision, 36 for contact lenses, 49
convergence and divergence amplitudes, 36–37, 115
of external structures, 29–30 eye movement (motility), 30–31 of fundus, 34–35
gonioscopy, 35, 149 ophthalmodynamometry, 35–36 photo-stress test, 36
pressure check (tonometry), 34, 145–46, 148–49
of pupils, 31, 227 refraction, 26–28
slit lamp exam, 32–33, 87 special eyedrops, 37 visual acuity, 24–26
visual fields, 29, 147–48, 227 Eyeglasses, 39–45
bifocals, 40–41, 44 and eye weakness, 2 frame selection, 42 lenses, 42–45 prescriptions of, 40–41 prisms for, 115 reading glasses, 43, 115
to treat accommodative esotropia, 111 trifocals, 44
wearing too much, 2 Eye history, 21–23 Eyelashes, 30
Eyelids disorders of
chalazia, 64–66, 74–75 ectropion, 73, 77–78 entropion, 73, 77–79 herpes infections, 267
inflammation (blepharitis), 59–64 Kaposi’s sarcoma, 268
molluscum contagiosum, 75, 267–68 ptosis, 79–81
S-shaped deformity, 30, 74 styes, 64–66
tumors, 74–77 twitching, 7–8 examination of, 29–30 lid hygiene/scrubs, 62
Eye movement (motility), 30–31 Eye muscles. See Muscles, eye
Eye ointments. See Ointments, eye Eye pressure. See Intraocular pressure Eyes. See also other Eye entries; specific
disorders anatomy of, 9–10, 10
anterior chamber, 13 choroid, 9, 16–17, 188, 235 ciliary body, 9, 14, 170, 235 conjunctiva, 12–13 cornea, 9, 10–12
external eye muscles, 18–19 iris, 9, 14–15, 235
lens, 15–16 optic nerve, 9, 18 pupil, 15
retina, 9, 17–18, 188 sclera, 9, 12–13
trabecular meshwork, 13–14 vitreous humor, 9, 16
angle of, 149
foreign bodies in, 6, 85–87 motility of, 30–31
weak, 2
Eye socket (orbit), 9
Eye straightness. See Muscles, eye
Farnsworth-Munsell 100 hue test, 36 Farsightedness. See Hyperopia Fasanella-Servat procedure, 81
Fats, animal cholesterol, 180–82 in diet, 278, 283–85
and macular degeneration, 203–6 types of, 283–84
Fatty acids
effect on retinopathy, 185 in infant eye health, 269–71
333
I N D E X
omega-3, 165–66, 284 omega-6, 269, 284
polyunsaturated, 269–71, 283–84 types of, 283–84
Feverfew, 249
Fiber, 285–86
Filtering procedure, 169–70 Flap microstriae, 53
Flare, 33, 237
Flashing lights, 7, 211–12 Flavonoids, 161, 303 Floaters, 7, 211–12
Folic acid (folate), 291 Follicles, 94
Foods. See Nutrition Foreign bodies, 6, 85–87 Fractures, blowout, 117 Free radicals, 125, 198 Fuch’s dystrophy, 87–88 Fundus, 34–35
Fungal infections, 90 Fusion, 31, 113
Galactosemia, 133–34 Genetics, 136, 189
Giant cell arteritis, 218, 230–31
Giant papillary conjunctivitis (GPC), 50–51 Ginkgo biloba
antioxidants in, 166
effect on retinopathy, 185–86 in treatment of uveitis, 241–42
Glasses. See Eyeglasses Glaucoma
and alcohol, 159
angle-closure, 14, 149–50, 167–68, 274 and blood flow, 151, 164–65
and caffeine, 157–58
chronic open angle, 14, 149, 150, 168–70, 273–74
congenital/infantile, 150 described, 145–46
diagnosis of, 1–2, 18, 34, 146–50 and exercise, 156–57
eye pressure checks for, 1–2, 34, 145–46, 148–49
and ginkgo biloba, 166 low-tension, 145–46 medications for, 150–56, 168 neovascular, 221
and omega-3 fatty acids, 165–66 phacolytic, 122
pigmentary, 15, 157 and pilocarpine, 160–61
recommendations for, 170–72 and rice diet, 162–64
and rutin, 160–61 secondary, 150, 272 and smoking, 157 surgery for, 167–70
and timing of meals, 161–62 and vitamin B1, 160
and vitamin C, 159–60 and water intake, 158–59
Glutathione, 125–26 Goldmann perimeter, 147 Goldmann tonometry, 34, 148 Gonioscopy, 35, 149
GPC (Giant papillary conjunctivitis), 50–51 Granular dystrophy, 90
Grave’s disease, 251
Greater occipital neuralgia, 244, 245 Gunn pupil, 227
Guttata, 33, 88
Hay fever, 98–100 Headaches
ice-cream, 246 migraine, 6, 246–50 muscle tension, 244–46 related eye problems, 250
Heart block, 152 Hemoglobin A1c, 174 Hemorrhage. See Bleeding Herpes viruses
and eyelid problems, 267 herpes simplex, 256–60
in conjunctivitis, 96, 257
in corneal infections, 90, 257–59 in eye complications, 259–60 recurrence of, 258–59 treatment of, 257–58
herpes zoster, 119, 260–63 and retinitis, 266
Hirschberg test, 108–9 Histoplasmosis, 222 Histo spots, 222
HIV (Human immunodeficiency virus). See AIDS
Hordeolum. See Chalazia; Styes Horner’s syndrome, 80, 247
Human immunodeficiency virus (HIV). See AIDS
Hydroxychloroquine, 272–73
Hyperopia (farsightedness) in children, 109, 110, 111 defined, 26–27, 39 versus presbyopia, 28
Hypertension
benign intracranial, 233 effect on eye, 215–16
334
I N D E X
and macular degeneration, 207 ophthalmologist in diagnosing, 216–17 retinopathy in, 216, 217
and vein occlusions, 216, 220 Hyperthyroidism, 250, 251–52 Hypothyroidism, 250, 251
IDDM (insulin-dependent diabetes mellitus), 173, 177
Idoxuridine, 258 Immune system, 195–96 Infants
DHA level in, 270–71 esotropia in, 108, 109–11 glaucoma in, 150
nutrition in eye health, 268–71 ptosis in, 79–80
tear duct problems in, 70–71 Infections
after cataract surgery, 141 conjunctivitis, 6, 13, 93–98 corneal, 90–93, 257–59 corneal ulcers, 11, 50, 90–93 determining cause of, 92 herpes, 90, 96, 256–63, 267
human immunodeficiency virus, 263–68 lymph nodes in, 30
molluscum contagiosum, 75, 267–68 periorbital cellulitis, 66 staphylococcal blepharitis, 61–62, 63 in tear sac, 70
toxoplasmosis, 224–26, 243 Inflammation
of choroid (choroiditis), 17 episcleritis, 101–3, 106
of eyelids (blepharitis), 59–64 of iris (iritis), 13, 31, 235
of tear gland (dacryoadenitis), 74 temporal arteritis, 218, 230–31 of uvea (uveitis), 14, 16, 235–43
of vitreous humor (vitritis), 235, 238, 240 Inflammatory bowel disease, 242
Injections, subconjunctival, 240 Injuries
blowout fractures, 117 and cataracts, 136 chemicals in eyes, 5
corneal abrasions, 11, 83–85, 91 corneal lacerations, 11, 85 foreign bodies in eye, 6, 85–87 and optic nerve damage, 232
Insulin-dependent diabetes mellitus (IDDM), 173, 177
Internal hordeolum. See Chalazia Intraocular lens implants, 140
Intraocular pressure (IOP) and alcohol, 159
and caffeine, 157–58 defined, 34
in diagnosing glaucoma, 34, 145–46, 148–49
and diet, 162–63 effect of LASIK on, 55 and exercise, 156–57
lowering with medication, 150–56 and prostaglandins, 163–64
and timing of meals, 161–62 in uveitis, 238
and vein occlusions, 220 and vitamin C, 159–60 and water intake, 158–59
Intrastromal corneal ring segments, 56 Iodine, 302
IOP. See Intraocular pressure Iopidine (apraclonidine), 153 Iridocyclitis, 235, 242 Iridotomy, 167, 274
Iris
anatomy of, 9, 10, 14–15, 235 examination of, 33 inflammation of, 13, 31, 235 rubeosis iridis, 15, 33
Iritis, 13, 31, 235
Iron, 193, 295–97
Ischemic optic neuropathy, 229–32 Isoflavones, 303
Itching, eye. See Allergies
Jones test, 72
Jones tube, 73
Kaposi’s sarcoma, 268
Kempner, Walter, 163, 181
Keratic precipitates, 237
Keratitis, 257, 259
Keratoconus, 90
Keratometer, 49
Lacerations, corneal, 11, 85
Lacrimal system. See Tears; Tear system Lacrisert, 69
Lasers
in cataract surgery, 1, 142
in glaucoma surgery, 167–69 in LASIK surgery, 53–56
neodymium: YAG laser, 142, 167 in PRK surgery, 54, 55, 56
in treating diabetic retinopathy, 178–80 in treating macular degeneration, 209–10 in treating retinal tears, 212
335
I N D E X |
|
in treatment of neovascularization, |
Magnesium, 183–84, 298–99 |
221–22, 223 |
Manganese, 193, 301 |
LASIK (laser in situ keratomileusis), 53–56 |
Map-dot fingerprint dystrophy, 89–90 |
Latanoprost, 154–55 |
Marginal hypersensitivity ulcer, 61 |
Lattice degeneration, 211 |
Meals, and diurnal rhythm, 161–62 |
Lattice dystrophy, 90 |
Medical history, 22 |
Lazy eye. See Amblyopia |
Medications. See also specific conditions; |
Legal blindness, 25 |
specific medications |
Lens |
allergies and sensitivity to, 23 |
anatomy of, 10, 15–16 |
causing headaches, 250 |
artificial implants of, 56–57, 140 |
effect on optic nerve, 151 |
in cataracts, 122–23, 125–26 |
eyedrops |
effect of LASIK on, 55 |
anesthetic (numbing), 84, 86 |
examination of, 33 |
artificial tears, 63–64, 68 |
protection from oxidation, 125–26 |
cycloplegic, 239 |
Lenses, eyeglasses. See also Contact lenses |
in diagnosing disorders, 37 |
bifocals, 40–41, 44 |
dilating, 84, 138–39 |
glass or plastic, 42 |
getting into child’s eyes, 98 |
prescriptions for, 40–41 |
eye ointments, 63, 69, 83–84, 88 |
progressive addition, 44–45 |
patient history of, 22–23 |
tinting, 42 |
side effects of |
trifocals, 44 |
anticancer drugs, 274–75 |
UV coating of, 42–43 |
antidepressants, 273–74 |
Levator muscle, 79–80, 81 |
anti-inflammatory drugs, 271–73 |
Lid hygiene/scrubs, 62 |
cholesterol-lowering drugs, 275 |
Lid myokymia, 7–8 |
sildenafil (Viagra), 276 |
Lutein |
tranquilizers, 273–74 |
and macular degeneration, 131, 201–3, 205 |
tuberculosis drugs, 276 |
in preventing cataracts, 131–32, 142 |
Men, cholesterol and zinc in, 194 |
Lycopene, 199, 203 |
Merté, H.-J., 162 |
Lymph nodes, 30 |
Microaneurysms, 177–78, 179 |
|
Migraine headaches, 6, 246–50 |
Macula. See also Macular degeneration |
Milk, 269 |
defined, 17, 188 |
Minerals |
holes in, 214–15 |
calcium, 297–98 |
puckers in, 215 |
copper, 191–93, 300–301 |
in retinopathy, 178, 179–80 |
iodine, 302 |
testing for problems of, 36 |
iron, 193, 295–97 |
Macular degeneration |
magnesium, 183–84, 298–99 |
and animal fats, 203–6 |
manganese, 193, 301 |
antioxidants in, 197–203, 205 |
phosphorus, 299 |
and cataracts, 137 |
selenium, 301–2 |
causes of, 189–90 |
zinc, 190–97, 299–300 |
development of, 188 |
Mohs’s micrographic surgery, 77 |
lifestyle related risks, 199, 206–7 |
Molluscum contagiosum, 75, 267–68 |
and lutein, 131, 201–3, 205 |
Monofixation syndrome, 112 |
self-monitoring in, 207–8 |
Monovision, 48 |
surgery for, 209–10 |
Motility (eye movement), 30–31 |
symptoms of, 187–88 |
Multiple sclerosis (MS), 119, 228–29 |
types of, 189 |
Muscle relaxation techniques, 245–46 |
and visual acuity, 26 |
Muscles, eye |
and zinc, 190–97, 205, 206 |
ciliary, 14 |
Macular dystrophy, 90 |
disorders of, 36–37 |
Macular edema, 275 |
amblyopia, 111–12 |
Maculopathy, diabetic, 179 |
double vision, 116–20 |
336
I N D E X |
|
esophoria, 115 |
magnesium, 183–84, 298–99 |
esotropia, 108–11 |
manganese, 193, 301 |
exophoria, 115 |
phosphorus, 299 |
exotropia, 112–15 |
selenium, 301–2 |
imbalances of, 120 |
zinc, 190–97, 299–300 |
external, 18–19, 109 |
and optic nerve damage, 233 |
levator, 79–80, 81 |
phytochemicals in, 302–4 |
Myasthenia gravis, 80–81, 117 |
in prevention of disease, 3, 277–79 |
Mycobacterium avium intracellulare, 266 |
protein in, 180, 191, 280–83 |
Myopia (nearsightedness), 26, 28, 39, 53 |
and retinopathy, 180–82 |
|
vitamins in |
Nasolacrimal duct, 30, 70–73 |
biotin, 291 |
Nearsightedness (myopia), 26, 28, 39, 53 |
folate, 291 |
Neodymium: YAG laser, 142, 167 |
pantothenic acid, 291 |
Neovascular glaucoma, 221 |
supplements, 3, 127–28, 206 |
Neovascularization |
vitamin A, 286–87 |
defined, 221–22 |
vitamin B1 (thiamin), 160, 287 |
and laser treatments, 178–79 |
vitamin B2 (riboflavin), 132, 287–88 |
subretinal, 223 |
vitamin B3 (niacin), 132, 275, 288 |
Nerves |
vitamin B6 (pyridoxine), 288–89 |
cranial, 117–18 |
vitamin B12 (cobalamin), 233, 289–90 |
palsy of, 117–19, 250 |
vitamin C, 125, 129–30, 143, 159–60, |
problems with in ptosis, 80 |
292 |
Neuralgia |
vitamin D, 292–93 |
greater occipital, 244, 245 |
vitamin E, 125, 130–31, 143, 293–94 |
postherpetic, 261–62, 263 |
vitamin K, 294 |
Niacin (vitamin B3), 132, 275, 288 |
|
Nicotinic acid. See Niacin |
Obesity, 135, 174 |
NIDDM (non-insulin-dependent diabetes |
Occipital cortex, 18 |
mellitus), 173–74, 183 |
Ocular histo, 222–24 |
Nodular episcleritis, 102, 103 |
Ocular hypertensives, 146 |
Nolvadex (tamoxifen), 274 |
Oil gland tumors, 74–75 |
Non-insulin-dependent diabetes mellitus |
Ointments, eye |
(NIDDM), 173–75, 183 |
in treating abrasions, 83–84 |
Nuclear sclerotic cataracts, 16, 123, 124, 135 |
in treating blepharitis, 63 |
Nucleus of lens, 15, 123 |
in treating corneal edema, 88 |
Nutrition |
in treating dry eye syndrome, 69 |
and blepharitis, 62–63 |
Omega-3 fatty acids, 284 |
and blood viscosity, 165–67 |
effect on retinopathy, 185 |
carbohydrates in, 279–80 |
and glaucoma, 165–66 |
and cataracts, 126–35 |
in infant eye health, 269–71 |
and diabetes, 174–76 |
Omega-6 fatty acids, 269, 284 |
fats in, 278, 283–85 |
Open angle glaucoma, chronic |
fiber in, 285–86 |
blood circulation in, 151 |
food as source of nutrients, 200 |
defined, 14, 149, 150 |
in infant vision, 268–71 |
effect of medications on, 273–74 |
leafy green vegetables in, 202–3, 205, 206 |
and omega-3 fatty acids in, 165 |
low carbohydrate, high protein diet in, 3 |
surgery for, 168–70 |
and macular degeneration, 190–206 |
Ophthalmodynamometry, 35–36 |
and migraine headaches, 250 |
Ophthalmologists, 216–17 |
minerals in |
Ophthalmometers, 49 |
calcium, 297–98 |
Ophthalmopathy, thyroid, 251–54 |
copper, 191–93, 300–301 |
Ophthalmoscopes, 34–35 |
iodine, 302 |
Optic cup, 18 |
iron, 193, 295–97 |
Optic disk, 18, 34, 146–47 |
337
